CCL5 and cystic fibrosis: So far we only know that c-Src is increased in CF and appears to be a bridge between the CFTR channel activity and MUC1 expression [17], and that RANTES expression might be modulated trough interactions involving PDZ binding domains and EBP50 related interactions [61].